Successful bailout of Sapien 3 valve balloon rupture during transcatheter valve implantation via transaortic approach

2019 ◽  
Vol 35 (4) ◽  
pp. 415-416 ◽  
Author(s):  
Takeshi Takamura ◽  
Ryosai Inoue ◽  
Tetsuya Seko ◽  
Toshiya Tokui ◽  
Atsunobu Kasai ◽  
...  
Keyword(s):  
Sapien 3 ◽  
Transcatheter Valve ◽  
Transaortic Approach ◽  
Valve Implantation

scholarly journals Effect of SAPIEN 3 Transcatheter Valve Implantation on Health Status in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk

2018 ◽  
Vol 11 (12) ◽  
pp. 1188-1198 ◽  
Author(s):  
Suzanne J. Baron ◽  
Vinod H. Thourani ◽  
Susheel Kodali ◽  
Suzanne V. Arnold ◽  
Kaijun Wang ◽  
...  
Keyword(s):  
Health Status ◽  
Aortic Stenosis ◽  
Severe Aortic Stenosis ◽  
Surgical Risk ◽  
Sapien 3 ◽  
Transcatheter Valve ◽  
Valve Implantation

scholarly journals Transcatheter Mitral Valve Replacement with the Edwards Sapien 3 Valve

2017 ◽  
Vol 44 (4) ◽  
pp. 269-273 ◽  
Author(s):  
Biswajit Kar ◽  
Angelo Nascimbene ◽  
Igor D. Gregoric ◽  
Manish Patel ◽  
Pranav Loyalka
Keyword(s):  
Mitral Valve ◽  
Valve Replacement ◽  
Mitral Valve Replacement ◽  
Mitral Valve Stenosis ◽  
Transcatheter Mitral Valve Replacement ◽  
Edwards Sapien ◽  
Sapien 3 ◽  
Transcatheter Valve ◽  
Valve Implantation ◽  
Surgical Valve Replacement

We describe the case of a 57-year-old man who had severe mitral valve stenosis and regurgitation without significant annular calcification. He was not a candidate for surgical valve replacement or repair because of his substantial comorbid conditions, overall frailty, and elevated surgical risk. He underwent successful transcatheter mitral valve replacement of his native mitral valve with compassionate, off-label use of an Edwards Sapien 3 valve. A search of the literature produced no other cases like ours, which represents a further evolution of the transcatheter valve implantation concept. Further studies are needed to help define accurate valve sizing, intraprocedural positioning, and long-term device stability, as well as to determine which patients might benefit from this commercially available valve. In the meantime, our findings could present a means of treating patients who have no other options.

scholarly journals PARTNER 2A & SAPIEN 3: TAVI for intermediate risk patients

2017 ◽  
Vol 2016 (4) ◽  
Author(s):  
Ahmed ElGuindy
Keyword(s):  
Lower Risk ◽  
Intermediate Risk ◽  
Surgical Risk ◽  
Transcatheter Aortic Valve ◽  
Risk Patients ◽  
Aortic Valve Implantation ◽  
Sapien 3 ◽  
Transcatheter Valve ◽  
Valve Implantation ◽  
Device Technology

Transcatheter aortic valve implantation (TAVI) is currently indicated for patients with severe symptomatic aortic stenosis who are unfit for surgery or when the surgical risk is high. Thanks to the increasing experience of surgeons, better patient selection, and substantial improvements in device technology, the procedure is now being performed with excellent outcomes and a progressively lower rate of complications. As a result, the cut-off threshold to implant a transcatheter valve is gradually moving toward lower risk patients. However, this is not supported by strong evidence from rigorous large clinical trials. The PARTNER 2A and SAPIEN 3 trials were conducted to address this gap in our knowledge. 

Transcatheter valve-in-valve implantation of the 'MedLab-KT' prosthesis

2020 ◽  
Vol 26 (1) ◽  
pp. 135
Author(s):  
A. B. Voevodin ◽  
A. A. Allenov ◽  
V. V. Bazylev
Keyword(s):  
Valve In Valve ◽  
Transcatheter Valve ◽  
Valve Implantation

A valve-in-valve transcatheter aortic valve implantation with commissural alignment using advanced imaging reconstruction: a case report

2020 ◽  
Vol 3 (10) ◽  
pp. 01-05
Author(s):  
Marco Angelillis
Keyword(s):  
Aortic Valve ◽  
Severe Aortic Stenosis ◽  
Coronary Intervention ◽  
Easy Access ◽  
Surgical Aortic Valve Replacement ◽  
Transcatheter Aortic Valve ◽  
Structural Valve Deterioration ◽  
Valve In Valve ◽  
Transcatheter Valve ◽  
Valve Implantation

Transcatheter valve in valve (ViV) implantation actually represents a valid alternative to surgical reinterventions in patients with previous surgical aortic valve replacement (AVR). In patients less than 80 years old, it is crucial to correctly position the new valve leaving a feasible and easy access to coronary ostia, both for future percutaneous coronary intervention (PCI) than for a future possible TAVinTAV procedure. We report a 71 year old man with prior AVR presented with structural valve deterioration (SVD) leading to severe aortic stenosis. In order to guarantee comfortable coronary access we aligned, the commissures of the new percutaneous valve with the ones of the surgical bioprothesis by reconstructing the headframes of the surgical bioprosthesis with computer tomography (CT) and fluoro-CT.

Sign in / Sign up

Export Citation Format

Share Document